A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
BioNTech SE
Kivu Bioscience Inc.
AstraZeneca
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Nammi Therapeutics Inc
Revolution Medicines, Inc.
Exscientia AI Limited
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Arcus Biosciences, Inc.
Agenus Inc.
Radiopharm Theranostics, Ltd
Sotio Biotech Inc.
Whitehawk Therapeutics, Inc.
Eli Lilly and Company
National Cancer Institute (NCI)
SystImmune Inc.
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
Dragonfly Therapeutics
Eli Lilly and Company
BeOne Medicines
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Clasp Therapeutics, Inc.
NiKang Therapeutics, Inc.
Verismo Therapeutics
Poseida Therapeutics, Inc.
MacroGenics
Royal Marsden NHS Foundation Trust
SystImmune Inc.
Pheon Therapeutics
SN BioScience
Eli Lilly and Company
Seagen Inc.
Seagen Inc.
Innate Pharma
Dren Bio
Novartis
NextCure, Inc.
Seagen Inc.